Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3854811 | 0.98 | HTR6 (0.39) | HTR6 | |
| SCHEMBL28175563 | 0.96 | HTR6 (0.36) | HTR6 | |
| SCHEMBL9557656 | 0.87 | HTR6 (0.36) | HTR6 | |
| SCHEMBL1386444 | 0.85 | MEN1 (0.33) | — | |
| Glycine SCHEMBL3848788 | 0.82 | SSTR4 (0.32) | HTR6 | |
| SCHEMBL21422730 | 0.82 | — | — | |
| SCHEMBL9557652 | 0.82 | — | — | |
| SCHEMBL1956709 | 0.80 | — | — | |
| SCHEMBL28881685 | 0.80 | HTR6 (0.40) | HTR6 | |
| Hydrochloric Acid SCHEMBL10434976 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334741-A1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | Sanford, L. P. (US) | 2011-06-22 | — | — | EP | claimed |
| WO-2010030451-A1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | SANFORD, L.P. (US) | 2010-03-18 | — | — | WO | claimed |
| US-20100063186-A1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | SANFORD, L.P. (US) | 2010-03-11 | — | — | US | claimed |
| US-11912723-B2 | KRAS modulators and uses thereof | QUANTA THERAPEUTICS, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230374042-A1 | KRAS MODULATORS AND USES THEREOF | QUANTA THERAPEUTICS, INC. | 2023-11-23 | — | — | US | disclosed |
| EP-2334741-B1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | SANFORD LP (US) | 2013-11-13 | — | — | EP | disclosed |
| EP-2334741-A1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | Sanford, L. P. (US) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010030451-A1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | SANFORD, L.P. (US) | 2010-03-18 | — | — | WO | disclosed |
| US-20100063186-A1 | WASHABLE INK COMPOSITIONS AND WRITING INSTRUMENTS COMPRISING SAME | SANFORD, L.P. (US) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230374042-A1 | KRAS MODULATORS AND USES THEREOF | KRAS, NRAS, HRAS | HTR6 4822/4885 |
| US-11912723-B2 | KRAS modulators and uses thereof | KRAS, NRAS, HRAS | HTR6 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.